Abstract
Acute metabolic disorders are relatively common amongst medical and surgical patients, especially in the critically ill. Whilst increasing the complexity of management plans, these circumstances also increase the risk of cardiac complications, such as arrhythmias, and furthermore are associated with increased mortality. Arrhythmic risk is promoted by electrolyte, acid-base and fluid balance disturbance, increased sympathetic drive and cardiac ischaemia. Particularly, electrolyte abnormalities may generate or facilitate clinical arrhythmias, even in the setting of normal cardiac tissue, by modulating ion conduction across (specific) cardiac cell membrane channels [1], and management of the underlying pathology may be all that is required to allow rapid normalisation of the metabolic profile. Moreover, complex pharmacological regimes may exacerbate the situation [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Bibliography
El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J. 2011;18:233–45.
Kraft MD, Btaiche IF, Sacks GS, et al. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62:1663–82.
Task FM, Zipes DP, Camm AJ, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27:2099–140.
Whalley DW, Wendt DJ, Grant AO. Electrophysiologic effects of acute ischemia and reperfusion and their role in the genesis of cardiac arrhythmias. In: Podrid PJ, Kowey PR, editors. Cardiac arrhythmia: mechanisms, diagnosis, and management. Baltimore: Williams & Wilkins; 1995. p. 109–30.
Ramaswamy K, Hamdan MH. Ischemia, metabolic disturbances, and arrhythmogenesis: mechanisms and management. Crit Care Med. 2000;28(Suppl):N151–7.
Nesher G, Zion MM. Recurrent ventricular tachycardia in hypothyroidism report of a case and review of the literature. Cardiology. 1988;75:301–6.
Osborn LA, Skipper B, Arellano I, et al. Results of resting and ambulatory electrocardiograms in patients with hypothyroidism and after return to euthyroid status. Heart Dis. 1999;1:8–11.
Singh AK, Nguyen PN. Refractory ventricular tachycardia following aortic valve replacement complicated by unsuspected pheochromocytoma. Thorac Cardiovasc Surg. 1993;41:372–3.
Michaels RD, Hays JH, O’Brian JT, et al. Pheochromocytoma associated ventricular tachycardia blocked with atenolol. J Endocrinol Invest. 1990;13:943–7.
Shimizu K, Miura Y, Meguro Y, et al. QT prolongation with torsades de pointes in pheochromocytoma. Am Heart J. 1992;124:235–9.
Viskin S, Fish R, Roth A, et al. Clinical problem-solving. QT or not QT? N Engl J Med. 2000;343:352–6.
Colao A. Are patients with acromegaly at high risk for dysrhythmias? Clin Endocrinol (Oxf). 2001;55:305–6.
Kahaly G, Olshausen KV, Mohr-Kahaly S, et al. Arrhythmia profile in acromegaly. Eur Heart J. 1992;13:51–6.
Colao A, Ferone D, Marzullo P, et al. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab. 2001;86:2779–86.
Minniti G, Moroni C, Jaffrain-Rea ML, et al. Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol (Oxf). 2001;55:307–13.
Suyama K, Uchida D, Tanaka T, et al. Octreotide improved ventricular arrhythmia in an acromegalic patient. Endocr J. 2000;47(Suppl):S73–5.
Lombardi G, Colao A, Marzullo P, et al. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study. J Endocrinol Invest. 2002;25:971–6.
Colao A, Marzullo P, Cuocolo A, et al. Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin Endocrinol (Oxf). 2003;58:169–76.
Izumi C, Inoko M, Kitaguchi S, et al. Polymorphic ventricular tachycardia in a patient with adrenal insufficiency and hypothyroidism. Jpn Circ J. 1998;62:543–5.
Abdo A, Bebb RA, Wilkins GE. Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. Can J Cardiol. 1999;15:347–8; 549.
Chang CJ, Chen SA, Tai CT, et al. Ventricular tachycardia in a patient with primary hyperparathyroidism. Pacing Clin Electrophysiol. 2000;23:534–7.
Wallace TM, Matthews DR. Recent advances in the monitoring and management of diabetic ketoacidosis. QJM. 2004;97:773–80.
Harrower C. The value of continuous ECG monitoring during treatment of diabetic ketoacidosis. A computer study. Acta Diabetol Lat. 1975;15:88–94.
American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: life-threatening electrolyte abnormalities. Circulation. 2005;112:IV-121–5.
Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004;27:153–60.
Brobst D. Review of the pathophysiology of alterations in potassium homeostasis. J Am Vet Med Assoc. 1986;188:1019–25.
Brown RS. Potassium homeostasis and clinical implications. Am J Med. 1984;77:3–10.
Yu AS. Atypical electrocardiographic changes in severe hyperkalemia. Am J Cardiol. 1990;77:906–8.
Martinez-Vea A, Bardaji A, Garcia C, Oliver JA. Severe hyperkalemia with minimal electrocardiographic manifestations: a report of seven cases. J Electrocardiol. 1999;32:45–9.
Moore ML, Bailey RR. Hyperkalaemia in patients in hospital. N Z Med J. 1989;102:557–8.
Stevens MS, Dunlay RW. Hyperkalemia in hospitalized patients. Int Urol Nephrol. 2000;32:177–80.
Paice B, Gray JM, McBride D, et al. Hyperkalaemia in patients in hospital. Br Med J (Clin Res Ed). 1983;286:1189–92.
Shemer J, Modan M, Ezra D, et al. Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci. 1983;19:659–61.
Surawicz B. Relationship between electrocardiogram and electrolytes. Am Heart J. 1967;73:814–34.
Freeman K, Feldman JA, Mitchell P, et al. Effects of presentation and electrocardiogram on time to treatment of hyperkalemia. Acad Emerg Med. 2008;15:239–49.
Fisch C. Relation of electrolyte disturbances to cardiac arrhythmias. Circulation. 1973;47:408–19.
Jackson MA, Lodwick R, Hutchinson SG. Hyperkalaemic cardiac arrest successfully treated with peritoneal dialysis. BMJ. 1996;312:1289–90.
Voelckel W, Kroesen G. Unexpected return of cardiac action after termination of cardiopulmonary resuscitation. Resuscitation. 1996;32:27–9.
Niemann JT, Cairns CB. Hyperkalemia and ionized hypocalcemia during cardiac arrest and resuscitation: possible culprits for postcountershock arrhythmias? Ann Emerg Med. 1999;34:1–7.
Slovis C, Jenkins R. Conditions not primarily affecting the heart. BMJ. 2002;324:1320–3.
Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med. 2000;18:721–6.
Webster A, Brady W, Morris F. Recognising signs of danger: EKG changes resulting from an abnormal serum potassium concentration. Emerg Med J. 2002;19:74–7.
Ettinger PO, Regan TJ, Oldewurtel HA. Hyperkalemia, cardiac conduction and the electrocardiogram: a review. Am Heart J. 1974;88:360–71.
Levine HD, Wanzer SH, Merrill JP. Dialyzable currents of injury in potassium intoxication resembling acute myocardial infarction or pericarditis. Circulation. 1956;13:29–36.
Paice BJ, Paterson KR, Onyanga-Omara F, et al. Record linkage study of hypokalemia in hospitalized patients. Postgrad Med J. 1986;62:187–91.
Schulman M, Narins RG. Hypokalemia and cardiovascular disease. Am J Cardiol. 1990;65:4E–9.
Thompson RG, Gobb LA. Hypokalemia after resuscitation out-of-hospital ventricular fibrillation. JAMA. 1982;248:2860–3.
Surawicz B, Braun HA, Crum WB, et al. Quantitative analysis of the electrocardiographic pattern of hypopotassemia. Circulation. 1957;16:750–63.
Surawicz B. Electrolytes and the electrocardiogram. Postgrad Med. 1974;55:123–9.
Yan GX, Lankipalli RS, Burke JK, Musco S, Kowey PR. Ventricular repolarization components of the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol. 2003;42:401.
Agus ZS, Wasserstein A, Goldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med. 1982;72:473–9.
Dyckner T, Wester PO. Relation between potassium, magnesium and cardiac arrhythmias. Acta Med Scand Suppl. 1981;647:163–9.
Navarro-Gonzalez JF. Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol. 1998;49:373–8.
Fiset C, Kargacin ME, Kondo CS, Lester WM, Duff HJ. Hypomagnesemia: characterization of a model of sudden cardiac death. J Am Coll Cardiol. 1996;27:1771–6.
Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J. 1994;128:564–74.
Bushinsky DA, Monk RD. Electrolyte quintet: calcium. Lancet. 1998;352:306–11.
Barri YM, Knochel JP. Hypercalcemia and electrolyte disturbances in malignancy. Hematol Oncol Clin North Am. 1996;10:775–90.
Aldinger KA, Samaan NA. Hypokalemia with hypercalcemia: prevalence and significance in treatment. Ann Intern Med. 1977;87:571–3.
Ziegler R. Hypercalcemic crisis. J Am Soc Nephrol. 2001;12 Suppl 17:S3–9.
Carlstedt F, Lind L. Hypocalcemic syndromes. Crit Care Clin. 2001;17:139–53.
Campistol JM, Almirall J, Montoliu J, Revert L. Electrographic alterations induced by hyperkalaemia simulating acute myocardial infarction. Nephrol Dial Transplant. 1989;4:233–5.
Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117:260–7.
Viallon AM, Zeni FM, Lafond PM, et al. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med. 1999;27:2690–3.
Committee M, Blomstrom-Lundqvist C, Scheinman MM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) Developed in collaboration with NASPE-Heart Rhythm Society. Eur Heart J. 2003;24:1857–97.
Friedman P, Stevenson W. Proarrhythmia. Am J Cardiol. 1998;82:50N–8.
Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36:3246–51.
Ngugi NN, McLigeyo SO, Kayima JK. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East Afr Med J. 1997;74:503–9.
Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis. 1996;28:508–14.
al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview [see comments]. Am J Kidney Dis. 1994;24:737–52.
Edelson GW, Kleerekoper M. Hypercalcemic crisis. Med Clin North Am. 1995;79:79–92.
Orchard CH, Cingolani HE. Acidosis and arrhythmias in cardiac muscle. Cardiovasc Res. 1994;28:1312–9.
Littmann L, Monroe MH, Taylor 3rd L, Brearley Jr WD. The hyperkalemic Brugada sign. J Electrocardiol. 2007;40:53–9.
Barold SS, Leonelli F, Herweg B. Hyperkalemia during cardiac pacing. Pacing Clin Electrophysiol. 2007;30:1–3.
Elliott MJ, Ronksley PE, Catherine M, Ahmed SB, Hemmelgarn BR. Management of patients with acute hyperkalemia. CMAJ. 2010;10:182–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bardari, S., D’Agata, B., Sinagra, G. (2016). Acute Management of Patients with Arrhythmias and Non-cardiac Diseases: Metabolite Disorders and Ion Disturbances. In: Zecchin, M., Sinagra, G. (eds) The Arrhythmic Patient in the Emergency Department. Springer, Cham. https://doi.org/10.1007/978-3-319-24328-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-24328-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24326-9
Online ISBN: 978-3-319-24328-3
eBook Packages: MedicineMedicine (R0)